Previous studies revealed that VEGF promotes angiogenesis through the activation of MAPK/ERK and Akt/m-TOR signaling pathway in ovarian cancer, hepatocellular carcinoma and non-small-cell lung cancer [51–53]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.